Related references
Note: Only part of the references are listed.Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis
Rikke Ratzer et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis
Rikke Ratzer et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Secondary Progressive Multiple Sclerosis: Definition and Measurement
Domenico Plantone et al.
CNS DRUGS (2016)
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study
Antonio Llombart-Cussac et al.
EUROPEAN JOURNAL OF CANCER (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Multi-State Models for Panel Data: ThemsmPackage forR
Christopher H. Jackson
Journal of Statistical Software (2015)
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Antonio Scalfari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
Jeremy Chataway et al.
LANCET (2014)
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study
E. Le Page et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
Christine Lebrun et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis:: a randomized placebo controlled multicentre study
D. Poehlau et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Tutorial in biostatistics: Competing risks and multi-state models
H. Putter et al.
STATISTICS IN MEDICINE (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials
L Kappos et al.
NEUROLOGY (2004)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen et al.
NEUROLOGY (2002)
Final analysis of the European multicenter trial on IFNβ-1b in secondary-progressive MS
L Kappos et al.
NEUROLOGY (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
